Single versus dual antiplatelet therapy for stroke prevention in patients with first-ever embolic stroke of undetermined source
In this ESUS cohort, DAPT was associated with fewer ischemic events and no increased major bleeding. The benefit was most evident at 6-12 months and was sustained over a longer follow-up period.
Authors
- Yerim Kim (ORCID: https://orcid.org/0000-0002-7108-6302)
- Hee‐Jin Im (ORCID: https://orcid.org/0000-0002-8979-6521)
- Joo Hye Sung (ORCID: https://orcid.org/0000-0003-2577-6350)
- Chulho Kim (ORCID: https://orcid.org/0000-0001-8762-8340)
- Minwoo Lee (ORCID: https://orcid.org/0000-0001-8474-5744)
- Sang‐Hwa Lee (ORCID: https://orcid.org/0000-0002-0609-1551)
- Jong-Hee Sohn
Institutions
- Hallym University (KR)
- Kangdong Sacred Heart Hospital (KR)
- Hallym University Dongtan Sacred Heart Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
- Hallym University Chuncheon Sacred Heart Hospital (KR)
Publication Details
- Journal
- International Journal of Stroke
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1177/17474930251398257
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00